Medicare Enrolled
Dr. Rana Bilbeisi, D.O.
Internal Medicine · Warren, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bilbeisi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bilbeisi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bilbeisi
Dr. Rana Bilbeisi is an internal medicine specialist in Warren, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bilbeisi performed 1,016 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bilbeisi received a total of $23,791 from 77 pharmaceutical and/or device companies across 806 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bilbeisi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 26% volume in MI
$23,791 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,016
Medicare services
Top 26% in MI for internal medicine
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
435 | $73 | $136 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
200 | $48 | $87 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
174 | $108 | $188 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
44 | $71 | $254 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $143 | $603 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
36 | $42 | $162 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $108 | $467 |
| New patient office visit, complex (60-74 min) | 31 | $144 | $282 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $65 | $222 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$23,791
Total received (2018-2024)
Avg $3,399/year across 7 years
Top 4% in MI for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
806
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,374
2023
$4,165
2022
$3,585
2021
$1,835
2020
$1,059
2019
$907
2018
$867
Payments by company (2024)
Gilead Sciences, Inc.
$4,399
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,652
Novartis Pharmaceuticals Corporation
$1,297
AstraZeneca Pharmaceuticals LP
$667
Genentech USA, Inc.
$330
PFIZER INC.
$293
ABBVIE INC.
$242
Incyte Corporation
$236
Janssen Biotech, Inc.
$210
Eisai Inc.
$172
Astellas Pharma US Inc
$172
Takeda Pharmaceuticals U.S.A., Inc.
$155
GENZYME CORPORATION
$149
Lilly USA, LLC
$116
SEAGEN INC.
$99
Daiichi Sankyo Inc.
$96
Celgene Corporation
$93
Aveo Pharmaceuticals, Inc.
$91
Ipsen Biopharmaceuticals, Inc
$90
Bayer Healthcare Pharmaceuticals Inc.
$77
SOBI, INC
$75
E.R. Squibb & Sons, L.L.C.
$70
Pharmacosmos Therapeutics Inc.
$68
Deciphera Pharmaceuticals Inc.
$54
Apellis Pharmaceuticals, Inc.
$44
Exelixis Inc.
$44
Coherus Biosciences Inc.
$43
Genmab U.S., Inc.
$43
ARRAY BIOPHARMA INC
$37
Stemline Therapeutics Inc.
$37
SERVIER PHARMACEUTICALS LLC
$30
Regeneron Healthcare Solutions, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
TAIHO ONCOLOGY, INC.
$20
Azurity Pharmaceuticals, Inc.
$20
GlaxoSmithKline, LLC.
$19
BeiGene USA, Inc.
$17
CSL Behring
$17
Janssen Pharmaceuticals, Inc
$16
Adaptive Biotechnologies Corporation
$16
Kite Pharma, Inc.
$15
MorphoSys, US Inc.
$13
Top 3 companies account for 64.6% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$4,491
Novartis Pharmaceuticals Corporation
$2,571
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,674
Genentech USA, Inc.
$1,152
Amgen Inc.
$1,126
AstraZeneca Pharmaceuticals LP
$1,067
Janssen Biotech, Inc.
$973
Astellas Pharma US Inc
$801
GENZYME CORPORATION
$764
PFIZER INC.
$730
Takeda Pharmaceuticals U.S.A., Inc.
$624
Incyte Corporation
$546
Lilly USA, LLC
$450
E.R. Squibb & Sons, L.L.C.
$414
Eisai Inc.
$355
Alexion Pharmaceuticals, Inc.
$316
Celgene Corporation
$306
Daiichi Sankyo Inc.
$302
Ipsen Biopharmaceuticals, Inc
$279
ABBVIE INC.
$265
NOVARTIS PHARMACEUTICALS CORPORATION
$250
SANOFI-AVENTIS U.S. LLC
$218
Dova Pharmaceuticals
$212
EISAI INC.
$211
Pharmacyclics LLC, An AbbVie Company
$207
Novocure GmbH
$200
Kite Pharma, Inc.
$196
Bayer Healthcare Pharmaceuticals Inc.
$163
Seagen Inc.
$150
SOBI, INC
$150
COMSORT, Inc
$150
Clovis Oncology, Inc.
$147
AbbVie Inc.
$138
G1 Therapeutics, Inc.
$124
Exelixis Inc.
$110
Deciphera Pharmaceuticals Inc.
$109
Myriad Genetic Laboratories, Inc.
$103
SEAGEN INC.
$99
Janssen Pharmaceuticals, Inc
$98
Global Blood Therapeutics, Inc.
$98
Aveo Pharmaceuticals, Inc.
$91
Pharmacosmos Therapeutics Inc.
$85
GlaxoSmithKline, LLC.
$85
SERVIER PHARMACEUTICALS LLC
$75
Stemline Therapeutics Inc.
$74
BeiGene USA, Inc.
$72
Merck Sharp & Dohme Corporation
$65
AVEO Pharmaceuticals, Inc.
$65
Genmab U.S., Inc.
$64
ARRAY BIOPHARMA INC
$54
Pharmacyclics LLC, an AbbVie Company
$49
Karyopharm Therapeutics Inc.
$48
PharmaEssentia USA Corporation
$48
Adaptive Biotechnologies Corporation
$45
Apellis Pharmaceuticals, Inc.
$44
Fortovia Therapeutics, Inc.
$43
Coherus Biosciences Inc.
$43
Blueprint Medicines Corporation
$40
Regeneron Healthcare Solutions, Inc.
$36
MorphoSys, US Inc.
$27
Kyowa Kirin, Inc.
$27
Sobi, Inc
$25
ImmunoGen, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
TAIHO ONCOLOGY, INC.
$20
Azurity Pharmaceuticals, Inc.
$20
Spectrum Pharmaceuticals Inc.
$18
CSL Behring
$17
TESARO, Inc.
$16
CTI BioPharma Corp.
$16
Mirati Therapeutics, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
UroGen Pharma, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
TerSera Therapeutics LLC
$12
PORTOLA PHARMACEUTICALS, INC.
$11
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ALIMTA · ALUNBRIG · ANDEXXA · AYVAKIT · Alecensa · Aranesp · Avastin · BENDEKA · BESREMI · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Balversa · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CUVITRU · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · EPKINLY · Elahere · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Gazyva · HYQVIA · Halaven · Hizentra · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JADENU · JAKAFI · JAYPIRCA · JELMYTO · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PRECISETUMOR · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · Somatuline Depot · Stivarga · TAFINLAR · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tibsovo · Trodelvy · Turalio · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VYNDAMAX · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · XARELTO · XGEVA · XPOVIO · XTANDI · Xtandi · Yescarta · ZEJULA · ZOLADEX · Zuplenz · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,859
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
Henry Ford Health Warren Hospital
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bilbeisi is a clinical cardiology specialist, with above-average Medicare volume (top 26% in MI), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bilbeisi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bilbeisi performed 435 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bilbeisi receive payments from pharmaceutical companies?
Yes. Dr. Bilbeisi received a total of $23,791 from 77 companies across 806 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bilbeisi's costs compare to other internal medicine physicians in Warren?
Dr. Bilbeisi's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bilbeisi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Warren
Browse internal medicine physicians in Warren ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MI
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MI
Which MI internal medicine physicians receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology